Antiprotozoal activities of phospholipid analogues (Q35077281)

6 August 2017

1 reference

title

Antiprotozoal activities of phospholipid analogues (English)

1 reference

6 August 2017

Simon L Croft

1

1 reference

PubMed ID

12615315

6 August 2017

Karin Seifert

series ordinal

2

1 reference

PubMed ID

12615315

6 August 2017

Michael Duchêne

series ordinal

3

1 reference

6 August 2017

1 February 2003

1 reference

Molecular and Biochemical Parasitology

6 August 2017

1 reference

6 August 2017

126

1 reference

6 August 2017

2

1 reference

6 August 2017

165-172

1 reference

Cytostatic activity of synthetic O-alkylglycerolipids

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

Phospholipid synthesis: Oxazaphospholanes and dioxaphospholanes as intermediates

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

Hexadecylphosphocholine: a new and selective antitumor drug

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

Syntheses and antimicrobial activities of alkyl lysophospholipids

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

Cytotoxicity of ester and ether lysophospholipids on Leishmania donovani promastigotes

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

Metabolism of ether lysophospholipids in Leishmania donovani promastigotes

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

The activity of alkyl phosphorylcholines and related derivatives against Leishmania donovani

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

Metabolism of 1-0-[1'-14C]octadecyl-sn-glycerol in Leishmania donovani promastigotes. Ether lipid synthesis and degradation of the ether bond

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

Membrane-interactive lipids as experimental anticancer drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

Antileishmanial activity of the ether phospholipid ilmofosine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

The activities of four anticancer alkyllysophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

Sensitivities of Leishmania species to hexadecylphosphocholine (miltefosine), ET-18-OCH(3) (edelfosine) and amphotericin B.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

Ether lipid metabolism, GPI anchor biosynthesis, and signal transduction are putative targets for anti-leishmanial alkyl phospholipid analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

Antileishmanial activity of rac-1-dodecyl-2-octanamido-2-deoxy-glycerophosphocholine, a new dialkylglycerophosphocholine, in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

Effect of platelet-activating factor on cell differentiation of Trypanosoma cruzi

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

Effect of platelet-activating factor on the process of cellular differentiation of Herpetomonas muscarum muscarum

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

Analogs of alkyllysophospholipids: chemistry, effects on the molecular level and their consequences for normal and malignant cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

Effects of miltefosine on various biochemical parameters in a panel of tumor cell lines with different sensitivities

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

Monitoring drug resistance in leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

Effect of the alkyl-lysophospholipids on the proliferation and differentiation of Trypanosoma cruzi

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

Mechanism of action of anti-proliferative lysophospholipid analogues against the protozoan parasite Trypanosoma cruzi: potentiation of in vitro activity by the sterol biosynthesis inhibitor ketoconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

Efficacy of anticancer alkylphosphocholines in Trypanosoma brucei subspecies

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

Distribution of hexadecylphosphocholine and octadecyl-methyl-glycero-3-phosphocholine in rat tissues during steady-state treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

Hexadecylphosphocholine: oral treatment of visceral leishmaniasis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

Short- and long-term efficacy of hexadecylphosphocholine against established Leishmania infantum infection in BALB/c mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

Suppression of posttreatment recurrence of experimental visceral Leishmaniasis in T-cell-deficient mice by oral miltefosine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

Visceral leishmanicidal activity of hexadecylphosphocholine (miltefosine) in mice deficient in T cells and activated macrophage microbicidal mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

Activities of hexadecylphosphocholine (miltefosine), AmBisome, and sodium stibogluconate (Pentostam) against Leishmania donovani in immunodeficient scid mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

Topical treatment with hexadecylphosphocholine (Miltex) efficiently reduces parasite burden in experimental cutaneous leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

Trial of oral miltefosine for visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

Oral treatment of visceral leishmaniasis with miltefosine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

Short-course of oral miltefosine for treatment of visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

The inhibition of cell signaling pathways by antitumor ether lipids

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

Mechanisms of action of phospholipid analogs as anticancer compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

Protein kinase C is not involved in the cytotoxic action of 1-octadecyl-2-O-methyl-sn-glycerol-3-phosphocholine in HL-60 and K562 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

The phospholipid analogue hexadecylphosphocholine inhibits phosphatidylcholine biosynthesis in Madin-Darby canine kidney cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

Induction of ceramide-mediated apoptosis by the anticancer phospholipid analog, hexadecylphosphocholine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

Alkylphosphocholines induce apoptosis in HL-60 and U-937 leukemic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

Ether--lipid (alkyl-phospholipid) metabolism and the mechanism of action of ether--lipid analogues in Leishmania

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

Phospholipid signalling pathways in Trypanosoma cruzi growth control

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

Pathways involved in environmental sensing in trypanosomatids.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

L-arginine-dependent suppression of apoptosis in Trypanosoma cruzi: contribution of the nitric oxide and polyamine pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

Investigations on the cellular uptake of hexadecylphosphocholine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

Alkyl-lysophospholipid resistance in multidrug-resistant Leishmania tropica and chemosensitization by a novel P-glycoprotein-like transporter modulator

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

Effects of miltefosine and other alkylphosphocholines on human intestinal parasite Entamoeba histolytica

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

Alkylphosphocholines: influence of structural variation on biodistribution at antineoplastically active concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

Acanthamoeba--the ultimate opportunist?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

Cytotoxic activities of alkylphosphocholines against clinical isolates of Acanthamoeba spp.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

Miltefosine--the long-awaited therapy for visceral leishmaniasis?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900283-9

7 January 2021

10.1016/S0166-6851(02)00283-9

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12615315